November 1, 2013
President Isao Teshirogi Shionogi delivered record earnings for six months through September as its hyperlipidemia medicine Crestor (rosuvastatin) and other strategic products drove up domestic sales, while its rigorous cost control also paid off, the company said on October 31...read more